Hyderabad-based Bharat Biotech's candidate vaccine for coronavirus got the nod for human trials earlier this month. The first trial has started on 375 people. The company's Chairman & MD Dr Krishna Ella speaks to India Today TV about the progress made so far and when Indians could expect it in the market, if all went well.Also Read: COVID-19 impact: Indian spices rise in demand for immunity properties, exports up 34% in June

Congress councilor from Mangaluru also claimed that he tried a number of medicines for coronavirus and only rum and eggs worked.

Coronavirus vaccine news update: Goldman Sachs believes that a coronavirus vaccine could be approved by the end of the year. It predicts Moderna and Pfizer's candidates to be the first ones to pass regulatory hurdles

COVAXIN, the country's first possible vaccine against COVID-19, will be tested on 1,125 healthy volunteers in two phases (phase 1 and 2)

Sharks in the pharma supply chains are stockpiling and black-marketing a key life-saving drug for Covid-19, an India Today investigation has found. Remdesivir, produced by America's Gilead Sciences, is touted as the best hope for critically-ill coronavirus patients for its ability to shorten recovery times in clinical trials. India Today's undercover investigation has found that those who need remdesivir to keep them alive may not be able to afford it because of its excessive pricing on the black market. But, who's at fault? Rajeev Dubey, Editor, Business Today explains.Also Read: Coronavirus vaccine update: COVAXIN human trials start at PGI Rohtak

Coronavirus vaccine: The human trial of COVAXIN has started in All India Institute of Medical Sciences in Patna and Post-Graduate Institute of Medical Sciences in Rohtak

Remdesivir, produced by America's Gilead Sciences, is touted as the best hope for critically-ill coronavirus patients for its ability to shorten recovery times in clinical trials.Gilead has licensed several drugmakers in India to make its generic versions. India Today's undercover investigation has found that those who need remdesivir to keep them alive may not be able to afford it because of its excessive pricing on the black market.

India has so far conducted 127,39,490 COVID-19 tests, including 3,26,826on Thursday alone; this is the seventh consecutive day that COVID-19 cases have increased by over 26,000, which can be attributed to higher number of daily tests

Coronavirus vaccine news: Lakshmi Mittal said that the importance of dedicated and ongoing research in this field cannot be overestimated

Nita Ambani expressed her gratitude to employees and volunteers who have helped Reliance Foundation in the fight against the COVID outbreak. She added that 'Using Jio's digital power, we aim to make affordable healthcare and quality education accessible to every Indian'

IIT Delhi launches coronavirus testing kit: The kit has been launched by Newtech Medical under the name 'Corosure'. Newtech will produce the affordable coronavirus testing kit

Coronavirus vaccine news update: Moderna has said that its experimental COVID-19 vaccine has shown that it is safe and provokes immune responses in all 45 health volunteers in an early-stage study

Covifor is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and children, hospitalised with severe symptoms of the disease

RIL AGM 2020 live updates: Reliance will work with other Indian companies, including start-ups, to vigorously promote \"Made-in-India\", \"Made-for-India\" and \"Made-for-the-World\" products, says Mukesh Ambani

Coronavirus vaccine update: In the human trials, Zydus will enroll over 1,000 subjects across multiple clinical study sites in the country

The World Health Organisation has stated that it won't be prudent to expect a perfect vaccine just yet. The warning comes on the back of a study by King's College, London that showed antibodies fighting COVID-19 in recovered patients began to wane away in three months

In India, BCG vaccination of children started in 1949. In 2019, at least 97 per cent of the 2.6 crore children received the TB vaccine. The vaccine in children prevents a simple TB from turning into a  systemic and affecting the brain and other organs

The Sechenov First Moscow State Medical University said that clinical trial began on June 18. The university added that it conducted human trials on a group of 38 volunteers in two batches

Bharat Biotech is developing the vaccine in collaboration with the ICMR. It has started human trials on its vaccine candidate, 'Covaxin', which is India's first indigenous COVID-19 vaccine. It is working to develop an initial capacity of 200 million vials of the vaccine

Of the 23,174 deaths reported till 8 am, Maharashtra accounted for the highest 10,289 fatalities followed by Delhi with 3,371 deaths, Gujarat with 2,045, Tamil Nadu with 1,966, Uttar Pradesh with 934, West Bengal with 934, Madhya Pradesh with 653, Rajasthan with 510 and Karnataka with 684 deaths